These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Chemotherapy of advanced measurable colon and rectal carcinoma with oral 5-fluorouracil, alone or in combination with cyclophosphamide or 6-thioguanine, with intravenous 5-fluorouracil or beta-2'-deoxythioguanosine or with oral 3(4-methyl-cyclohexyl)-1(2-chlorethyl)-1-nitrosourea: a Phase II-III study of the Eastern Cooperative Oncology Group (EST 4273). Douglass HO; Lavin PT; Woll J; Conroy JF; Carbone P Cancer; 1978 Dec; 42(6):2538-45. PubMed ID: 365312 [TBL] [Abstract][Full Text] [Related]
5. 5 FU infusion with mitomycin-C vs. 5 FU infusion with methyl-CCNU in the treatment of advanced upper gastrointestinal cancer: a Southwest Oncology Group Study. Buroker T; Kim PN; Groppe C; McCracken J; O'Bryan R; Panettiere F; Costanzi J; Bottomley R; King GW; Bonnet J; Thigpen T; Whitecar J; Haas C; Vaitkevicius VK; Hoogstraten B; Heilbrun L Cancer; 1979 Oct; 44(4):1215-21. PubMed ID: 387204 [TBL] [Abstract][Full Text] [Related]
6. Metastatic colorectal carcinoma. A prospective randomized trial of Methyl-CCNU, 5-Fluorouracil (5-FU) and vincristine (MOF) versus MOF plus streptozotocin (MOF-Strep). Kemeny N; Yagoda A; Braun D Cancer; 1983 Jan; 51(1):20-4. PubMed ID: 6217886 [TBL] [Abstract][Full Text] [Related]
7. Eastern Cooperative Oncology Group experience with chemotherapy for inoperable gallbladder and bile duct cancer. Falkson G; MacIntyre JM; Moertel CG Cancer; 1984 Sep; 54(6):965-9. PubMed ID: 6235908 [TBL] [Abstract][Full Text] [Related]
8. An Eastern Cooperative Oncology Group evaluation of combinations of methyl-CCNU, mitomycin C, Adriamycin, and 5-fluorouracil in advanced measurable gastric cancer (EST 2277). Douglass HO; Lavin PT; Goudsmit A; Klaassen DJ; Paul AR J Clin Oncol; 1984 Dec; 2(12):1372-81. PubMed ID: 6439836 [TBL] [Abstract][Full Text] [Related]
9. Chemotherapy of large bowel carcinoma--fluorouracil (FU) + hydroxyurea (HU) vs. methyl-CCNU, oncovin, fluorouracil, and streptozotocin (MOF-Strep). An Eastern Cooperative Oncology Group study. Engstrom PF; MacIntyre JM; Schutt AJ; Douglass HO Am J Clin Oncol; 1985 Oct; 8(5):358-61. PubMed ID: 2932908 [TBL] [Abstract][Full Text] [Related]
10. 5FU infusion with mitomycin-C versus 5 FU infusion with methyl-CCNU in the treatment of advanced colon cancer: a Southwest Oncology Group Study. Buroker T; Kim PN; Groppe C; McCracken J; O'Bryan R; Panettiere F; Coltman C; Bottomley R; Wilson H; Bonnet J; Thigpen T; Vaitkevicius VK; Hoogstraten B; Heilbrun L Cancer; 1978 Sep; 42(3):1228-33. PubMed ID: 359121 [TBL] [Abstract][Full Text] [Related]
11. Trials of single-agent and combination chemotherapy for advanced cancer of the pancreas. Horton J; Gelber RD; Engstrom P; Falkson G; Moertel C; Brodovsky H; Douglass H Cancer Treat Rep; 1981; 65(1-2):65-8. PubMed ID: 6452948 [TBL] [Abstract][Full Text] [Related]
18. A randomized study of two different schedules of methyl CCNU, 5-FU and vincristine for metastatic colorectal carcinoma. Kemeny N; Yagoda A; Braun D; Golbey R Cancer; 1979 Jan; 43(1):78-82. PubMed ID: 367575 [TBL] [Abstract][Full Text] [Related]
19. Phase III comparison of the treatment of advanced gastrointestinal cancer with bolus weekly 5-FU vs. methyl-CCNU plus bolus weekly 5-FU. A Southwest Oncology Group study. Baker LH; Talley RW; Matter R; Lehane DE; Ruffner BW; Jones SE; Morrison FS; Stephens RL; Gehan EA; Vaitkevicius VK Cancer; 1976 Jul; 38(1):1-7. PubMed ID: 779949 [TBL] [Abstract][Full Text] [Related]
20. Combination chemotherapy (5-fluorouracil, methyl-CCNU, mitomycin C) versus 5-fluorouracil alone for advanced previously untreated colorectal carcinoma. A phase III study of the Piedmont Oncology Association. Richards F; Case LD; White DR; Muss HB; Spurr CL; Jackson DV; Cooper MR; Zekan P; Cruz J; Stuart JJ J Clin Oncol; 1986 Apr; 4(4):565-70. PubMed ID: 3514806 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]